The Enhancement of Iopanoate Excretion by Taurocholate

Experiments in dogs equipped with Thomas cannulas show that the calculated maximum excretion rate (Emax) of iopanoic acid is closely linked to the rate of bile salt excretion (Gastroenterology 1978;74:174–181). The Emax increases in an apparently linear manner from 0.20–2.36 /μmole/min/kg as the rat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Investigative radiology 1980-11, Vol.15 Suppl 6 (6 Suppl), p.S116-S121
Hauptverfasser: BERK, ROBERT N, BARNHART, JAMES L, GOLDBERGER, LAWRENCE E
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page S121
container_issue 6 Suppl
container_start_page S116
container_title Investigative radiology
container_volume 15 Suppl 6
creator BERK, ROBERT N
BARNHART, JAMES L
GOLDBERGER, LAWRENCE E
description Experiments in dogs equipped with Thomas cannulas show that the calculated maximum excretion rate (Emax) of iopanoic acid is closely linked to the rate of bile salt excretion (Gastroenterology 1978;74:174–181). The Emax increases in an apparently linear manner from 0.20–2.36 /μmole/min/kg as the rate of bile salt excretion increases from 0.21–2.62 μmole/min/kg. From the slope of the relation between the biliary excretion of bile salts and the Emax of iopanoate, it can be determined that 0.89 μmole of iopanoate is coupled with each μmole of bile salt. The mechanism by which bile salts enhance the Emax of iopanoate is difficult to determine from such studies. However, it is apparent that it is the taurocholate excretion per se and not the increase in bile flow that facilitates the excretion of iopanoate. Stimulation of bile flow with SC2644 (canalicular bile flow) or with secretin (ductular bile flow) has no influence on the rate of excretion of iopanoate. A physiochemical interaction between bile salts and iopanoate in bile could play a role in preventing back diffusion of iopanoate across the canalicular membrane. The coupling of iopanoate and bile salt molecules in bile at a ratio of 0.89 during maximum excretion of iopanoate is consistent with molecular ratios found between certain lipids and bile salts in mixed micelles. Because iopanoate is not a choleretic, it is possible that iopanoate is rendered osmotically inactive by entry into bile salt micelles. However, studies with other organic anions in rats indicate that binding to bile salt micelles does not always correlate with the facilitative action of bile salts on the biliary excretion of organic anions. Another possibility could be the mechanism postulated by Forker and Gibson for BSP. They propose that a carrier for BSP on the canalicular membrane reacts allosterically with taurocholate to produce, in effect, a second carrier with different kinetic parameters that can transport additional BSP. Goresky et al suggest that bile salts facilitate the biliary excretion of bilirubin by recruitment of the canalicular transport process in the centrilobular portion of the liver. The mechanism also could explain the influence of bile salts on iopanoate excretion. An important effect of bile salts on iopanoate excretion is suggested by the results of experiments in normal human volunteers. In these studies, 8 of 10 fasted volunteers failed to have gallbladder opacification with iopanoic acid compared to satis
doi_str_mv 10.1097/00004424-198011001-00024
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_75452900</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>75452900</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3004-d2c29b0acd39b7622e9337d81a660a0ff4e5ec1a29fb544b1b2a5c2087e7d0123</originalsourceid><addsrcrecordid>eNp1kctOwzAQRS0EKqXwCUhZsQuMH4njJaoKVEJiU9aW40yUQhIXO1Hp3-PS0h2zGWnunYfOEJJQuKeg5APEEIKJlKoCKAWgaawwcUamNON5CozCOZnGEqRKqfySXIXwsbdI4BMykQy4onxK8lWDyaJvTG-xw35IXJ0s3cb0zgxR-LYeh7Xrk3KXrMzonW1cG5VrclGbNuDNMc_I-9NiNX9JX9-el_PH19TyeGBaMctUCcZWXJUyZwwV57IqqMlzMFDXAjO01DBVl5kQJS2ZySyDQqKsgDI-I3eHuRvvvkYMg-7WwWLbmh7dGLTMRMYUQDQWB6P1LgSPtd74dWf8TlPQe2T6D5k-IdO_yGLr7XHHWHZYnRqPjKIuDvrWtQP68NmOW_S6QdMOjf7vE_wHXLt0vw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>75452900</pqid></control><display><type>article</type><title>The Enhancement of Iopanoate Excretion by Taurocholate</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>BERK, ROBERT N ; BARNHART, JAMES L ; GOLDBERGER, LAWRENCE E</creator><creatorcontrib>BERK, ROBERT N ; BARNHART, JAMES L ; GOLDBERGER, LAWRENCE E</creatorcontrib><description>Experiments in dogs equipped with Thomas cannulas show that the calculated maximum excretion rate (Emax) of iopanoic acid is closely linked to the rate of bile salt excretion (Gastroenterology 1978;74:174–181). The Emax increases in an apparently linear manner from 0.20–2.36 /μmole/min/kg as the rate of bile salt excretion increases from 0.21–2.62 μmole/min/kg. From the slope of the relation between the biliary excretion of bile salts and the Emax of iopanoate, it can be determined that 0.89 μmole of iopanoate is coupled with each μmole of bile salt. The mechanism by which bile salts enhance the Emax of iopanoate is difficult to determine from such studies. However, it is apparent that it is the taurocholate excretion per se and not the increase in bile flow that facilitates the excretion of iopanoate. Stimulation of bile flow with SC2644 (canalicular bile flow) or with secretin (ductular bile flow) has no influence on the rate of excretion of iopanoate. A physiochemical interaction between bile salts and iopanoate in bile could play a role in preventing back diffusion of iopanoate across the canalicular membrane. The coupling of iopanoate and bile salt molecules in bile at a ratio of 0.89 during maximum excretion of iopanoate is consistent with molecular ratios found between certain lipids and bile salts in mixed micelles. Because iopanoate is not a choleretic, it is possible that iopanoate is rendered osmotically inactive by entry into bile salt micelles. However, studies with other organic anions in rats indicate that binding to bile salt micelles does not always correlate with the facilitative action of bile salts on the biliary excretion of organic anions. Another possibility could be the mechanism postulated by Forker and Gibson for BSP. They propose that a carrier for BSP on the canalicular membrane reacts allosterically with taurocholate to produce, in effect, a second carrier with different kinetic parameters that can transport additional BSP. Goresky et al suggest that bile salts facilitate the biliary excretion of bilirubin by recruitment of the canalicular transport process in the centrilobular portion of the liver. The mechanism also could explain the influence of bile salts on iopanoate excretion. An important effect of bile salts on iopanoate excretion is suggested by the results of experiments in normal human volunteers. In these studies, 8 of 10 fasted volunteers failed to have gallbladder opacification with iopanoic acid compared to satisfactory gallbladder visualization in 10 of 10 fed volunteers. Furthermore, Craig and Caster showed that patients with impaired gallbladder visualization in the absence of biliary tract disease had elevated serum cholate. In comparison, patients with nonvisualization of the gallbladder due to gallbladder disease had normal serum cholate.</description><identifier>ISSN: 0020-9996</identifier><identifier>EISSN: 1536-0210</identifier><identifier>DOI: 10.1097/00004424-198011001-00024</identifier><identifier>PMID: 7203913</identifier><language>eng</language><publisher>United States: Copyright Wolters Kluwer Health, Inc. All rights reserved</publisher><subject>Animals ; Bile - metabolism ; Dogs ; Gallbladder Diseases - diagnostic imaging ; Gallbladder Diseases - metabolism ; Infusions, Parenteral ; Iopanoic Acid - metabolism ; Kinetics ; Liver Diseases - diagnostic imaging ; Liver Diseases - metabolism ; Radiography ; Taurocholic Acid - administration &amp; dosage ; Taurocholic Acid - metabolism</subject><ispartof>Investigative radiology, 1980-11, Vol.15 Suppl 6 (6 Suppl), p.S116-S121</ispartof><rights>Copyright © 1980 Wolters Kluwer Health, Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7203913$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>BERK, ROBERT N</creatorcontrib><creatorcontrib>BARNHART, JAMES L</creatorcontrib><creatorcontrib>GOLDBERGER, LAWRENCE E</creatorcontrib><title>The Enhancement of Iopanoate Excretion by Taurocholate</title><title>Investigative radiology</title><addtitle>Invest Radiol</addtitle><description>Experiments in dogs equipped with Thomas cannulas show that the calculated maximum excretion rate (Emax) of iopanoic acid is closely linked to the rate of bile salt excretion (Gastroenterology 1978;74:174–181). The Emax increases in an apparently linear manner from 0.20–2.36 /μmole/min/kg as the rate of bile salt excretion increases from 0.21–2.62 μmole/min/kg. From the slope of the relation between the biliary excretion of bile salts and the Emax of iopanoate, it can be determined that 0.89 μmole of iopanoate is coupled with each μmole of bile salt. The mechanism by which bile salts enhance the Emax of iopanoate is difficult to determine from such studies. However, it is apparent that it is the taurocholate excretion per se and not the increase in bile flow that facilitates the excretion of iopanoate. Stimulation of bile flow with SC2644 (canalicular bile flow) or with secretin (ductular bile flow) has no influence on the rate of excretion of iopanoate. A physiochemical interaction between bile salts and iopanoate in bile could play a role in preventing back diffusion of iopanoate across the canalicular membrane. The coupling of iopanoate and bile salt molecules in bile at a ratio of 0.89 during maximum excretion of iopanoate is consistent with molecular ratios found between certain lipids and bile salts in mixed micelles. Because iopanoate is not a choleretic, it is possible that iopanoate is rendered osmotically inactive by entry into bile salt micelles. However, studies with other organic anions in rats indicate that binding to bile salt micelles does not always correlate with the facilitative action of bile salts on the biliary excretion of organic anions. Another possibility could be the mechanism postulated by Forker and Gibson for BSP. They propose that a carrier for BSP on the canalicular membrane reacts allosterically with taurocholate to produce, in effect, a second carrier with different kinetic parameters that can transport additional BSP. Goresky et al suggest that bile salts facilitate the biliary excretion of bilirubin by recruitment of the canalicular transport process in the centrilobular portion of the liver. The mechanism also could explain the influence of bile salts on iopanoate excretion. An important effect of bile salts on iopanoate excretion is suggested by the results of experiments in normal human volunteers. In these studies, 8 of 10 fasted volunteers failed to have gallbladder opacification with iopanoic acid compared to satisfactory gallbladder visualization in 10 of 10 fed volunteers. Furthermore, Craig and Caster showed that patients with impaired gallbladder visualization in the absence of biliary tract disease had elevated serum cholate. In comparison, patients with nonvisualization of the gallbladder due to gallbladder disease had normal serum cholate.</description><subject>Animals</subject><subject>Bile - metabolism</subject><subject>Dogs</subject><subject>Gallbladder Diseases - diagnostic imaging</subject><subject>Gallbladder Diseases - metabolism</subject><subject>Infusions, Parenteral</subject><subject>Iopanoic Acid - metabolism</subject><subject>Kinetics</subject><subject>Liver Diseases - diagnostic imaging</subject><subject>Liver Diseases - metabolism</subject><subject>Radiography</subject><subject>Taurocholic Acid - administration &amp; dosage</subject><subject>Taurocholic Acid - metabolism</subject><issn>0020-9996</issn><issn>1536-0210</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1980</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kctOwzAQRS0EKqXwCUhZsQuMH4njJaoKVEJiU9aW40yUQhIXO1Hp3-PS0h2zGWnunYfOEJJQuKeg5APEEIKJlKoCKAWgaawwcUamNON5CozCOZnGEqRKqfySXIXwsbdI4BMykQy4onxK8lWDyaJvTG-xw35IXJ0s3cb0zgxR-LYeh7Xrk3KXrMzonW1cG5VrclGbNuDNMc_I-9NiNX9JX9-el_PH19TyeGBaMctUCcZWXJUyZwwV57IqqMlzMFDXAjO01DBVl5kQJS2ZySyDQqKsgDI-I3eHuRvvvkYMg-7WwWLbmh7dGLTMRMYUQDQWB6P1LgSPtd74dWf8TlPQe2T6D5k-IdO_yGLr7XHHWHZYnRqPjKIuDvrWtQP68NmOW_S6QdMOjf7vE_wHXLt0vw</recordid><startdate>198011</startdate><enddate>198011</enddate><creator>BERK, ROBERT N</creator><creator>BARNHART, JAMES L</creator><creator>GOLDBERGER, LAWRENCE E</creator><general>Copyright Wolters Kluwer Health, Inc. All rights reserved</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>198011</creationdate><title>The Enhancement of Iopanoate Excretion by Taurocholate</title><author>BERK, ROBERT N ; BARNHART, JAMES L ; GOLDBERGER, LAWRENCE E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3004-d2c29b0acd39b7622e9337d81a660a0ff4e5ec1a29fb544b1b2a5c2087e7d0123</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1980</creationdate><topic>Animals</topic><topic>Bile - metabolism</topic><topic>Dogs</topic><topic>Gallbladder Diseases - diagnostic imaging</topic><topic>Gallbladder Diseases - metabolism</topic><topic>Infusions, Parenteral</topic><topic>Iopanoic Acid - metabolism</topic><topic>Kinetics</topic><topic>Liver Diseases - diagnostic imaging</topic><topic>Liver Diseases - metabolism</topic><topic>Radiography</topic><topic>Taurocholic Acid - administration &amp; dosage</topic><topic>Taurocholic Acid - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>BERK, ROBERT N</creatorcontrib><creatorcontrib>BARNHART, JAMES L</creatorcontrib><creatorcontrib>GOLDBERGER, LAWRENCE E</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Investigative radiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>BERK, ROBERT N</au><au>BARNHART, JAMES L</au><au>GOLDBERGER, LAWRENCE E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Enhancement of Iopanoate Excretion by Taurocholate</atitle><jtitle>Investigative radiology</jtitle><addtitle>Invest Radiol</addtitle><date>1980-11</date><risdate>1980</risdate><volume>15 Suppl 6</volume><issue>6 Suppl</issue><spage>S116</spage><epage>S121</epage><pages>S116-S121</pages><issn>0020-9996</issn><eissn>1536-0210</eissn><abstract>Experiments in dogs equipped with Thomas cannulas show that the calculated maximum excretion rate (Emax) of iopanoic acid is closely linked to the rate of bile salt excretion (Gastroenterology 1978;74:174–181). The Emax increases in an apparently linear manner from 0.20–2.36 /μmole/min/kg as the rate of bile salt excretion increases from 0.21–2.62 μmole/min/kg. From the slope of the relation between the biliary excretion of bile salts and the Emax of iopanoate, it can be determined that 0.89 μmole of iopanoate is coupled with each μmole of bile salt. The mechanism by which bile salts enhance the Emax of iopanoate is difficult to determine from such studies. However, it is apparent that it is the taurocholate excretion per se and not the increase in bile flow that facilitates the excretion of iopanoate. Stimulation of bile flow with SC2644 (canalicular bile flow) or with secretin (ductular bile flow) has no influence on the rate of excretion of iopanoate. A physiochemical interaction between bile salts and iopanoate in bile could play a role in preventing back diffusion of iopanoate across the canalicular membrane. The coupling of iopanoate and bile salt molecules in bile at a ratio of 0.89 during maximum excretion of iopanoate is consistent with molecular ratios found between certain lipids and bile salts in mixed micelles. Because iopanoate is not a choleretic, it is possible that iopanoate is rendered osmotically inactive by entry into bile salt micelles. However, studies with other organic anions in rats indicate that binding to bile salt micelles does not always correlate with the facilitative action of bile salts on the biliary excretion of organic anions. Another possibility could be the mechanism postulated by Forker and Gibson for BSP. They propose that a carrier for BSP on the canalicular membrane reacts allosterically with taurocholate to produce, in effect, a second carrier with different kinetic parameters that can transport additional BSP. Goresky et al suggest that bile salts facilitate the biliary excretion of bilirubin by recruitment of the canalicular transport process in the centrilobular portion of the liver. The mechanism also could explain the influence of bile salts on iopanoate excretion. An important effect of bile salts on iopanoate excretion is suggested by the results of experiments in normal human volunteers. In these studies, 8 of 10 fasted volunteers failed to have gallbladder opacification with iopanoic acid compared to satisfactory gallbladder visualization in 10 of 10 fed volunteers. Furthermore, Craig and Caster showed that patients with impaired gallbladder visualization in the absence of biliary tract disease had elevated serum cholate. In comparison, patients with nonvisualization of the gallbladder due to gallbladder disease had normal serum cholate.</abstract><cop>United States</cop><pub>Copyright Wolters Kluwer Health, Inc. All rights reserved</pub><pmid>7203913</pmid><doi>10.1097/00004424-198011001-00024</doi></addata></record>
fulltext fulltext
identifier ISSN: 0020-9996
ispartof Investigative radiology, 1980-11, Vol.15 Suppl 6 (6 Suppl), p.S116-S121
issn 0020-9996
1536-0210
language eng
recordid cdi_proquest_miscellaneous_75452900
source MEDLINE; Journals@Ovid Complete
subjects Animals
Bile - metabolism
Dogs
Gallbladder Diseases - diagnostic imaging
Gallbladder Diseases - metabolism
Infusions, Parenteral
Iopanoic Acid - metabolism
Kinetics
Liver Diseases - diagnostic imaging
Liver Diseases - metabolism
Radiography
Taurocholic Acid - administration & dosage
Taurocholic Acid - metabolism
title The Enhancement of Iopanoate Excretion by Taurocholate
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T14%3A40%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Enhancement%20of%20Iopanoate%20Excretion%20by%20Taurocholate&rft.jtitle=Investigative%20radiology&rft.au=BERK,%20ROBERT%20N&rft.date=1980-11&rft.volume=15%20Suppl%206&rft.issue=6%20Suppl&rft.spage=S116&rft.epage=S121&rft.pages=S116-S121&rft.issn=0020-9996&rft.eissn=1536-0210&rft_id=info:doi/10.1097/00004424-198011001-00024&rft_dat=%3Cproquest_cross%3E75452900%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=75452900&rft_id=info:pmid/7203913&rfr_iscdi=true